Influenza virus infections have been associated with superimposed bacterial infections, primarily Streptococcus pneumoniae, Staphylococcus aureus, and group A Streptococcus (Streptococcus pyogenes) [1] [2] [3] [4] [5] , by affecting innate and adaptive immune responses to a variety of bacteria [6] [7] [8] , by increased binding and invasion of bacteria, and by increased viral replication [9] .
The data on secondary bacterial infections associated with the 2009-2010 influenza A (H1N1) pandemic are still emerging [10] ; however, a high rate of bacterial super-infection has been identified in children who have died from the novel pandemic H1N1 influenza virus (pH1N1) [11] .
Adults and children infected with pH1N1 appear to have different rates of bacterial coinfection. Among adults, clinically significant bacterial coinfections have been less prominent. Histologic specimens of lung tissue from 74 patients who died of pH1N1 revealed bacterial coinfections in 22 (29%), a rate that is markedly lower than for previous influenza pandemics [10] . In contrast, 43% of pediatric deaths from pH1N1 in the United States were associated with culture-confirmed bacterial coinfection [11] .
Although clinical and animal models suggest a relationship between influenza virus infection and bloodstream infection (BSI) [4, 8, 12] , population-based estimates provide a more robust epidemiologic association. Previous efforts at such population-based estimates [2, 13, 14] included the overlapping effects of other circulating viruses during the respiratory season. The unique seasonality of pH1N1 in the summer months, the lack of introduction of a vaccine until the end of the epidemic in Israel, the ability to clearly capture and define rates of BSI among persons of all ages, and our ability to find previous influenza and pH1N1 epidemic activities prompted this study. Therefore, the main objective of our investigation was to compare the age-specific incidence rates of S. pneumoniae, S. aureus, and S. pyogenes BSIs in seasonal and pH1N1 influenza seasons in Israel.
METHODS
This study estimated the differences in the incidences of S. pneumoniae, S. aureus, and S. pyogenes BSIs in 3 seasonal influenza epidemics during 2006-2009 and those during the pH1N1 outbreak.
Influenza Virus Surveillance
In Israel, a national, year-round, laboratory-based surveillance for influenza virus is conducted by the Weekly Sentinel System of the Israeli Centers for Disease Control (ICDC). Sentinel clinics located around the country monitor the number of outpatient visits and provide respiratory samples from patients with acute respiratory symptoms. These samples are tested for influenza virus using a polymerase chain reaction (PCR) assay at the Central Virology Laboratory in Tel Aviv with use of standard methods [15] .
The start of influenza virus-active periods (influenza-active weeks) was defined for each season as the first day of the first of 2 consecutive weeks with at least 2 influenza isolates per week. Likewise, the end of the season was declared after 2 consecutive weeks passed with ,2 influenza isolates per week; the end date was defined as the last day before this 2-week period. The winter seasons were defined from weeks 41 until the end of influenza virus activity. Influenza nonactive fall-winter weeks were defined as the winter weeks when influenza virus was not circulating. The 4 weeks following the influenza season were defined as the postinfluenza period. The summer season was defined as weeks 30-40 of the year.
Bacterial Isolates Surveillance
The ICDC collects and registers data on BSIs due to S. pneumoniae, S. aureus, and S. pyogenes from the computerized system of Clalit Health Maintenance Organization (HMO), the largest HMO in Israel, which runs 8 hospitals across the country. Each isolate is registered in the computerized system of the local laboratory and then automatically transferred via the Clalit Headquarter to the ICDC. In cases in which an individual patient had multiple blood cultures performed with the same organism within 10 days, only one culture was counted for the analysis. We also recorded the total number of blood cultures performed at these 8 hospitals in each week of the study period.
Statistical Methods
Age-wise weekly rates of BSI due to these pathogens were examined in relation to the timing of influenza season, postinfluenza period, and inter-influenza period (summer reference). BSI rates (per 100 000 person-years [PY]) for each age group were calculated according to age-specific population cared for by these hospitals in the Clalit HMO in each year of the study. These hospitals are located across the country and, according to The Israeli Ministry of Health data, provide medical care for one-third of the Israeli population (2 466 666 persons). In Israel, because access to the regional hospitals is free for Israeli citizens with no administrative limitations, the population treated at these hospitals represents all demographic groups. Data regarding the size of the population and of each age group in each of the study years were retrieved from the Annual Statistic Reports of Israel, which publish demographic data regarding the Israeli population following an annual census. Data were recorded into a Microsoft Excel spreadsheet, and the v 2 test was used to compare BSI incidence between populations with defined sizes. This test was used to examine the null hypothesis that BSI rates in the different age groups did not differ among the different seasons. Spearman's rank correlation test was used for examining the association between the weekly isolation of S. pneumoniae and S. aureus to examine the hypothesis that there is an inverse correlation between infection with these 2 microorganisms. The study was approved by the Ethics Committee of Wolfson Medical Center. Table 1 ; online only).
RESULTS

Seasonal
The total number of blood cultures performed during the pH1N1 influenza pandemic was considerably higher, compared with the previous 3 years, in all age groups, with the highest increase among children ,15 years of age (Supplementary  Table 2 ; online only).
S. aureus bacteremia accounted for the majority of isolates (1031 isolates), followed by S. pneumoniae (723) and S. pyogenes (116).
Pneumococcal BSI
The rates of S. pneumoniae BSI during summers and winters of 2006-2010 in the different age groups are presented in Table 1 , and Figure 1 .
During 2006-2009, there were significantly higher rates of pneumococcal BSI in the winter than in the summer seasons (6.96 vs 2.75 cases per 100 000 PY; incidence rate ratio [IRR], 2.55; 95% confidence interval [CI], 1.9-3.4; P , .0001). In addition, during 2006-2009, there were higher rates of S. pneumoniae BSI in the entire population during the winter weeks when influenza virus was circulating (influenza-active weeks), compared with the other winter weeks (influenza-non-active weeks; 8.2 vs 6.96 case per 100 000 PY; IRR, 1.7; 95% CI, 1.3-2.1; P , .0001).
The pH1N1 influenza-active period (week 24 in 2009 through week 7 in 2010) was characterized by several unique features. First, there were significantly higher rates of S. pneumoniae BSI during the summer and during the winter weeks of 2009-2010, compared with the respective calendar weeks of the previous 3 years. This rate remained significantly high even when the rate for the whole winter of 2009-2010 was compared with the mean rate during previous winters of 2006-2009 (IRR, 1.5; 95% CI, 1.2-1.9; P , .0001) and when the pH1N1 winter active weeks were compared with only influenza virus-active weeks in the previous 3 seasons (IRR, 1.3; 95% CI, 1.1-1.6; P , .0001) ( Table 1) . Second, the increase in S. pneumoniae bacteremia rates during the pH1N1 influenza season was confined to younger age groups (children aged 0-14 years) ( Table 1) . Data from the Central Laboratory of the Israeli Ministry of Health showed that there were no significant changes in the dynamics of S. pneumoniae serotypes during the study period (M. Bromberg, L. Valinski, unpublished observations).
S. pneumoniae BSI During Postinfluenza Periods
Analysis of the 4 weeks following the influenza season (postinfluenza period) showed significantly higher rates of S. pneumoniae BSI during the 4-week period following the pH1N1 influenza outbreak (Table 1 ; mean postinfluenza/influenza BSI IRR for the entire population, 1.8; 95% CI, 1.5-2.1; P , .0001), whereas this effect was not observed during the postinfluenza period of 2006-2009 seasons (IRR, .8; P 5 .13).
S. aureus BSI S. aureus BSI occurred mainly in the older population. There was no prominent seasonality of S. aureus BSI and no consistent increase in the rates during the winters of 2006-2009, compared with the respective summers (Table 2, Figure 2 ). However, there were higher rates of S. aureus BSI among almost all age groups during the different phases of the 2009-2010 pH1N1 influenza outbreak: during the summer (IRR, 1.6; 95% CI, 1.4-1.9; P , .0001) and during the winter (IRR, 1.5; 95% CI, 1.2-1.7; P , 0001), compared with the 3 previous seasonal influenza seasons. There was no statistically significant association between the weekly isolation rates of S. aureus and S. pneumoniae. The proportion of methicillin-resistant S. aureus (MRSA) BSI did not significantly change during the study years or between influenza-active and influenza-nonactive periods. We were not able to differentiate between hospital-acquired and community-acquired MRSA isolates; however, the isolation of community-acquired MRSA is still rare in Israel [16] .
S. pyogenes BSI
During 2006-2009, rates of invasive S. pyogenes infection were not seasonal and were not increased during influenza seasons, compared with the rest of the winter weeks. The pH1N1 influenza activity period was characterized by higher rates of S. pyogenes BSI (Table 2, Figure 3 ). The combined rate for all age groups was higher during the 2009 summer (IRR, 2.7; 95% CI, 1.6-4.6; P , .0001), compared with the summers of 2006-2008. In addition, higher S. pyogenes BSI rates were recorded during the winter activity period of pH1N1 virus, compared with seasonal influenza virus-active weeks during the previous 3 seasons (IRR, 3.3; 95% CI, 1.9-5.8; P , .0001). The increase was detected mainly among children (,5 years of age) and among adults 15-64 years of age.
DISCUSSION
Secondary bacterial infections have been identified as a major contributor to influenza-associated morbidity and mortality [4, 6] , and S. pneumoniae and S. aureus were blamed for the high fatality rate during the 1918 Spanish influenza pandemic [5] . Animal models have also demonstrated the potential ability of influenza virus to induce both respiratory and systemic bacterial infections [9, 12] . Figure 1 . Top: Streptococcus pneumoniae bacteremia rates (in 100 000 person-years), in differing age groups during the study years at the summers (A) and the winters (B ). Bottom: An asterisk indicates a significantly higher rate during pH1N1 in the specific age groups. For detailed P values and relative risks please refer to Table 1 . The definitions of ''summer'' and ''influenza active weeks'' are written in the ''Methods'' section. Several mechanisms for viral-bacterial synergism have been demonstrated in animal models, including airway modifications that favor bacterial growth, upregulation of ligands for bacterial adherence, and viral-induced defects in immune responses [17] [18] [19] . An enhanced inflammatory response during coinfection may also lead to worse outcomes [20] .
However, the epidemiological evidence for influenza virusbacterial synergism is contradictory [13] . Thus, the ability of other seasonal respiratory pathogens to induce bacterial infections [21] and the variable effectiveness of influenza vaccines [22, 23] might affect BSI rates.
The outbreak of pH1N1 influenza during 2009-2010 had several features that provided a unique opportunity to assess the impact of influenza on secondary invasive bacterial infections. First, this virus was active during the summer and, therefore, allowed us to compare the rate of BSI during the summer of 2009 with that during previous summers without the confounding effects of the other seasonal respiratory viruses that are active during the winter. In addition, because there was no available vaccine for pH1N1 influenza virus until the late stages of H1N1 epidemic in Israel and vaccination rates with this vaccine were very low, the confounding protective effects of vaccines were minimal. Third, the age-specific predilection of pH1N1 virus to cause disease in children and young adults, compared with the effects on older persons of a seasonal influenza, offered a unique opportunity to study and disclose, in an age-specific manner, the impact on BSI.
Our data clearly showed that the 2009-2010 pH1N1 pandemic had several striking features. During the summer of 2009, there were significantly higher rates of BSI, compared with mean rates during the previous summers of 2006-2008 (IRRs were 2.7, 2, and 1.6 for S. pyogenes, S. pneumoniae, and S. aureus, respectively). Higher rates were also observed during the 2009-2010 winter, compared with the mean rates during 2006-2009 influenza-active weeks (IRRs were 3.3, 1.3, and 1.5 for S. pyogenes, S. pneumoniae, and S. aureus, respectively). The pandemic outbreak was associated with a sharp increase in S. pyogenes and S. aureus BSI, although no seasonality of these Figure 2 . Top: Staphylococcus aureus bacteremia rates (in 100 000 person-years), in differing age groups during the study years at the summers (A) and the winters (B ). Bottom: An asterisk indicates a significantly higher rate during pH1N1 in the specific age groups. For detailed P values and relative risks please refer to Table 2 . The definitions of ''summer'' and ''influenza active weeks'' are written in the ''Methods'' section.
infections was noted during earlier seasonal influenza seasons. There was a significantly different pattern in the age-specific attack rates of BSI during the H1N1 pandemic. Children, especially those ,5 years of age who had the highest infection rates of pH1N1 influenza virus [24] , also had the highest increase in BSI, compared with adults and older persons. The IRRs for BSI among children ,5 years of age during the summer of 2009, compared with the previous 3 summers, were 14.8 for S. pneumoniae, 8.8 for S. pyogenes, and 5.9 for S. aureus. There were distinct differences between pneumococcal BSI during pH1N1 and seasonal influenza outbreaks, with a dramatic increase in pneumococcal BSI among children but not among adults. These findings are in accord with the data showing that pH1N1 influenza-associated morbidity was most prevalent among children and young adults. The increased rates of S. pneumoniae among children could be attributable to the massive infection of children during the 2009-2010 pandemic. Indeed, 50% of Israeli children had serologic evidence of infection with pH1N1, compared with only 23% and 10% of adults and persons .65 years of age, respectively [25] . The intense morbidity among young children is also demonstrated by the increased number of blood cultures performed in this population during pH1N1 influenza seasons, compared with the 3 previous seasons.
The rates of S. aureus BSI were higher in almost all age groups during the different phases of H1N1 pandemic. Apparently, the increased rate of S. aureus BSI during the pH1N1 outbreak has not been derived only from the increased rate of blood cultures (and increased number of infected individuals), because in the 3 previous influenza outbreaks, we found no evidence of seasonality in S. aureus BSI.
Our findings suggest that not all influenza strains have the same ability to induce secondary bacterial infections [12] . Although influenza strains that were prevalent during 2006-2009 exposed children and adults mainly to pneumococcal infections without a significant increase in S. pyogenes and Figure 3 . Top: Streptococcus pyogenes bacteremia rates (in 100 000 person-years), in differing age groups during the study years at the summers (A) and the winters (B ). Bottom: An asterisk indicates a significantly higher rate during pH1N1 in the specific age groups. For detailed P values and relative risks please refer to Table 2 . The definitions of ''summer'' and ''influenza active weeks'' are written in the ''Methods'' section.
S. aureus BSI, pH1N1 influenza infections appeared to increase the susceptibility to all 3 pathogens. The discrepancy between S. pneumoniae and S. aureus BSI in the adult population could not be explained by the theory suggesting that a lower rate of respiratory tract colonization with S. pneumoniae promotes S. aureus colonization [26, 27] , because we did not find an inverse correlation between the temporal isolation of these 2 pathogens in our population. A substantially higher coverage of the older population with the 23-valent pneumococcal polysaccharide vaccine that was achieved by Clalit Health Services during 2007-2009 may account, in part, for the difference in the dynamics of S. pneumoniae and S. aureus BSI during 2009-2010 in the older population [28] .
On the other hand, introduction of the conjugated 7-valent pneumococcal vaccine was probably not a significant confounder. This vaccine had been introduced for optional use in Israel in 2006 and has been included in the routine Israeli vaccination program since July 2009. Therefore, if this vaccine were a confounder, it would only have lessened the effect of the increased S. pneumonia BSI rates found among young children during the pH1N1 pandemic.
Although only a small fraction of secondary bacterial infections are bacteremic, our findings suggest that a substantial burden of influenza and, especially, pH1N1 influenza is caused by secondary BSI. Increased BSI rates may account for a significant part of the influenza-associated morbidity, although at the time of bacterial infection, some of these patients had already tested negative for influenza.
The increased incidence of S. pneumoniae during the postinfluenza period of the pH1N1 epidemic may support the notion that a significant part of influenza-associated morbidity is still detected later, although the virus is no longer circulating. An epidemiological model has demonstrated a lag time of 1-3 weeks in the relation between invasive S. pneumoniae disease and influenza [2] . In addition, animal models suggest that influenza virus causes a long-term modification of the lung microenvironment by a desensitization to bacterial products and an increase in the myeloid-negative regulator CD200 receptor that may predispose to bacterial colonization and infection [29] . Respiratory syncytial virus circulation did not account for this effect, because according to the ICDC monitoring, it was already after its peak during the 2009-2010 postinfluenza season period (M. Bromberg, unpublished observations).
An increase or decrease in the incidence of BSI could be attributable to altered routines in culturing. However, no active interventions or routine changes in blood culture practices were introduced during 2006-2010. In addition, the temporal association found between influenza virus-active periods and BSI might also have been affected by other seasonally active viruses. However, by comparing the summer of 2009 with the 2006-2008 summer baseline periods as the reference period, we were probably able to limit this interference. Of note, an increased rate of BSI during 2009 H1N1 pandemic influenza virus-active periods, suggests but does not provide direct evidence for involvement of the viruses in the pathogenesis of BSI. Finally, we could not differentiate between outpatient-and inpatientassociated BSI, we could not determine the clinical features of these infections or the case-fatality rates, and we could not rule out nosocomial infections. These, however, should not be seasonal, and our primary outcome measure being IRRs should not have been overly influenced by these limitations.
In conclusion, our population-based study indicates that influenza infections are associated with excess bacterial BSI, which could potentially be dramatic. The extent of this morbidity, the age-specific susceptibility, and the variety of bacteria causing BSI change according to the predominant influenza virus strains circulating during the specific season. Therefore, part of the preparedness for influenza pandemic should include awareness of these invasive infections and measures for their prevention.
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